Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/1996
12/19/1996WO1996040780A1 Transglutaminase cross-linkable polypeptides and methods relating thereto
12/19/1996WO1996040779A1 Peptide fragments of tissue factor and their use for treatment and prevention of clotting disorders
12/19/1996WO1996040778A1 TCR Vβ5 PEPTIDES
12/19/1996WO1996040777A2 Synthetic peptides and pharmaceutical compositions comprising them
12/19/1996WO1996040776A1 Methods for purifying authentic igf from yeast hosts
12/19/1996WO1996040775A1 Method for the treatment of corticosteroid induced osteopenia
12/19/1996WO1996040774A1 Complexes of modified lymphotoxins as pharmaceutical preparations
12/19/1996WO1996040773A1 Method for purifying thrombopoietin
12/19/1996WO1996040772A2 Agonist peptide dimers
12/19/1996WO1996040771A1 SINGLE CHAIN ANALOGS OF THE TGF-β SUPERFAMILY (MORPHONS)
12/19/1996WO1996040770A2 Anti-fungal d-amino acid histatin-based peptides
12/19/1996WO1996040769A1 Developmentally-regulated endothelial cell locus-1
12/19/1996WO1996040768A2 Anti-fungal and anti-bacterial histatin-based peptides
12/19/1996WO1996040767A2 E6ap-binding proteins
12/19/1996WO1996040766A2 Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins
12/19/1996WO1996040765A1 PROMOTION OF HOMOLOGOUS DNA PAIRING BY RecA-DERIVED PEPTIDES
12/19/1996WO1996040764A2 Nucleotide and amino acid sequences of hypervariable region 1 of the envelope 2 gene of hepatitis c virus
12/19/1996WO1996040763A2 Peptides for hiv-1 detection
12/19/1996WO1996040762A1 Monocyte chemotactic protein-4
12/19/1996WO1996040760A2 Iodine-containing peptides and their use as x-ray contrast media
12/19/1996WO1996040759A1 Antiviral peptoid compounds
12/19/1996WO1996040756A1 Radiometal-binding analogues of leutenizing hormone releasing hormone
12/19/1996WO1996040750A1 Peptides and compounds that bind to a thrombopoietin receptor
12/19/1996WO1996040749A1 Compounds and peptides that bind to the erythropoietin receptor
12/19/1996WO1996040736A1 Method of producing igf-i and igfbp-3 with correct folding and disulfide bonding
12/19/1996WO1996040731A1 Pegylated modified proteins
12/19/1996WO1996040730A1 Preparation of an acylated protein powder
12/19/1996WO1996040729A1 A method of cross-linking amino acid-containing polymers using photoactivatable chemical cross-linkers
12/19/1996WO1996040722A1 Chromosomal expression of heterologous genes in bacterial cells
12/19/1996WO1996040719A1 Endothelial-monocyte activating polypeptide iii
12/19/1996WO1996040718A1 Expression of lipoproteins
12/19/1996WO1996040717A1 High-affinity nucleic acid ligands of cytokines
12/19/1996WO1996040713A1 Cellular apoptosis susceptibility protein (csp) and antisense csp
12/19/1996WO1996040709A1 Pna-dna chimeras and pna synthons for their preparation
12/19/1996WO1996040685A1 Improved synthons for the synthesis and deprotection of peptide nucleic acids under mild conditions
12/19/1996WO1996040657A1 Inhibitors of phospholipase a¿2?
12/19/1996WO1996040647A1 α-(1,3-DICARBONYLENOL ETHER) METHYL KETONES AS CYSTEINE PROTEASE INHIBITORS
12/19/1996WO1996040637A1 Stable reagents for the preparation of radiopharmaceuticals
12/19/1996WO1996040294A1 Hiv-1 prophylactic composition and method
12/19/1996WO1996040291A1 Radiolabeled peptide compositions for site-specific targeting
12/19/1996WO1996040290A1 Immunological combination compositions and methods
12/19/1996WO1996040289A1 Thiolation of peptides for radionuclide-based radiodetection and radiotherapy
12/19/1996WO1996040271A1 Treatment of hemoglobinopathies
12/19/1996WO1996040268A1 Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
12/19/1996WO1996040267A1 The regulation of systemic immune responses utilizing cytokines and antigens
12/19/1996WO1996040264A1 Separation of active complexes
12/19/1996WO1996040251A1 Prevention and treatment of sepsis
12/19/1996WO1996040244A1 Antibodies to porcine cd34 positive cells and uses therefor
12/19/1996WO1996040241A1 Recombinant poxvirus-rabies compositions and combination compositions and uses
12/19/1996WO1996040236A1 Isolated formylated bacterial peptides, nucleic acid molecules and uses thereof
12/19/1996WO1996040231A1 Method for obtaining receptor agonist antibodies
12/19/1996WO1996040230A1 Vaccination with peptide of mhc class ii molecules for treatment of autoimmune disease
12/19/1996WO1996040229A1 Vaccines synthesized by transgenic plants
12/19/1996WO1996040227A1 Tumor associated epitopes
12/19/1996WO1996040221A1 Wound healing formulations containing human plasma fibronectin
12/19/1996WO1996040219A1 Inhibin compositions and methods of enhancing production performance
12/19/1996WO1996040217A1 Thrombopoietin compositions
12/19/1996WO1996040215A1 Treating immune deficiency diseases using t cell receptor peptides
12/19/1996WO1996040214A1 Novel anti-apoptotic compositions and methods using same
12/19/1996WO1996040213A1 Manufacture and purification of peptides
12/19/1996WO1996040212A1 Retrovirus vectors for expression of cii-ta and activation of hla class ii gene expression and uses thereof
12/19/1996WO1996040211A1 Use of conotoxin peptides u002 and mii for treating or detecting small-cell lung carcinoma
12/19/1996WO1996040209A1 Method for identifying or isolating a molecule and molecules identified thereby
12/19/1996WO1996040208A1 Novel mu opioid receptor ligands: agonists and antagonists
12/19/1996WO1996040206A1 Novel kappa receptor selective opioid peptides
12/19/1996WO1996040203A1 Methods of treatment using growth hormone antagonists
12/19/1996WO1996040202A1 Synthesis of n-substituted oligomers
12/19/1996WO1996040199A1 Methods of inhibiting phagocytosis
12/19/1996WO1996040197A1 aPL IMMUNOREACTIVE PEPTIDES, CONJUGATES THEREOF AND METHODS OF TREATMENT FOR aPL ANTIBODY-MEDIATED PATHOLOGIES
12/19/1996WO1996040196A1 Appetite regulating compositions
12/19/1996WO1996040194A1 Stable formulations of mhc-peptide complexes
12/19/1996WO1996040193A1 CYCLIC ANALOGS OF PTH AND PTHrP
12/19/1996WO1996040191A1 The treatment of hiv and other viral infections using combinatory therapy
12/19/1996WO1996040189A1 Peptides and compounds that bind to a receptor
12/19/1996WO1996040188A1 Reducing gelation of a fatty acid-acylated protein
12/19/1996WO1996040187A1 Surface-modifying copolymers having cell adhesion properties
12/19/1996WO1996040186A1 Relaxin-like factor and methods and uses thereof
12/19/1996WO1996040185A1 Relaxin analogs and derivatives methods and uses thereof
12/19/1996WO1996040066A1 A METHOD FOR ELICITING A Th1-SPECIFIC IMMUNE RESPONSE
12/19/1996WO1996040041A2 Antibodies to fas antigen capable of inhibiting apoptosis
12/19/1996WO1996040040A2 Thrombin receptor homolog
12/19/1996WO1996040039A2 Isolated nucleic acid molecules, peptides which form complexes with mhc molecule hla-a2 and uses thereof
12/19/1996WO1996039843A1 Controlling hemipteran insect pests with bacillus thuringiensis
12/19/1996WO1996039841A1 Tumor- or cell-specific herpes simplex virus replication
12/19/1996WO1996039834A1 Peptides and pharmaceutical compositions thereof for treatment of disorders or diseases associated with abnormal protein folding into amyloid or amyloid-like deposits
12/19/1996WO1996039830A1 Pericardial therapeutic and diagnostic agent delivery
12/19/1996WO1996039805A1 Plant glutamate receptors
12/19/1996WO1996039803A1 Use of the indeterminate gametophyte gene for maize improvement
12/19/1996WO1996039802A1 Hypersensitive response induced resistance in plants
12/19/1996WO1996036722A3 Embedded expression of heterologous proteins
12/19/1996DE19521945A1 Kaskadenpolymere mit Iodaromaten Cascade polymers with iodoaromatics
12/19/1996DE19521412A1 Neue kationische und polykationische Amphiphile, diese enthaltende Reagenzien und deren Verwendung New cationic and polycationic amphiphiles containing these reagents and their use
12/19/1996DE19521314A1 Adhärenzgen aus Helicobacter pylori und davon codiertes Polypeptid Adhärenzgen from Helicobacter pylori and it polypeptide encoded
12/19/1996DE19521313A1 Purificn. of Factor-VIII by affinity chromatography
12/19/1996DE19521312A1 Verfahren zur Identifizierung sekretorischer Gene aus Helicobacter pylori A method for identifying secretory genes from Helicobacter pylori
12/19/1996CA2787069A1 Vaccine for porcine reproductive and respiratory syndrome virus
12/19/1996CA2786782A1 Vaccine for porcine reproductive and respiratory syndrome virus
12/19/1996CA2704354A1 Expression of lipoproteins
12/19/1996CA2628032A1 Agonist peptide dimers
12/19/1996CA2451973A1 Method of increasing the solubility of tissue factor pathway inhibitor